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Using microelectrode techniques we compared the effects of tetrodotoxin (TTX, [2] [3] ,M), DL-propranolol (1-3 p,g/ml), and flecainide acetate (10-15 ,uM) on isolated canine ventricular epicardial (epicardium) and endocardial (endocardium) tissues. Propranolol, TTX, and flecainide decreased Vm.. and phase 0 amplitude in a use-dependent manner in both tissues.
The effects of propranolol were slow to develop and wash out. TTX and propranolol always abbreviated action potential duration in endocardium. Action potential duration was abbreviated by 23.8+5.6 msec after propranolol (1 gg/ml, basic cycle length [BCL] =1,000 msec) and 10 .8±+12.9 msec after TTX (2 ,uM, BCL=1,000 msec). In epicardium, the reduction of phase 0 and 1 amplitudes led to a slowing of the second action potential upstroke and an increase in the amplitude of phase 2. This accentuation of the notch resulted in a paradoxical prolongation of the epicardial action potential. Action potential duration was prolonged 34 .4±11.3 msec after 4 hours of exposure to propranolol (1 ,ug/ml, BCL=1,000 msec), 11 .1±6.3 msec after 15 minutes of exposure to TTX (2 ,uM, BCL= 1,000 msec), and 19.9+8.2 msec after 25-45 minutes of exposure to flecainide (15 ,uM, BCL=500 msec). With stronger sodium block, phase 1 terminated at more negative potentials, the second upstroke often failed to appear, and an all-or-none repolarization ensued causing a marked abbreviation of the epicardial action potential. In some epicardial preparations, we observed marked abbreviation at some sites but prolongation at other sites after sodium blockade with flecainide. The dispersion of repolarization was often attended by reentrant activity. The differential response of epicardium and endocardium to sodium blockade was not observed when the preparations were pretreated with 4-aminopyridine or ryanodine, agents known to diminish the transient outward current and epicardial notch. Acceleration-induced prolongation of refractoriness was observed after sodium blockade in epicardium but not in endocardium. Postrepolarization refractoriness also occurred in epicardium but not in endocardium after TTX, propranolol, or flecainide exposure.
The data indicate that propranolol, TTX, and flecainide, via their action to block sodium current, may exert opposite effects on action potential duration and refractoriness in cells spanning the ventricular wall. The presence of the transient outward current in epicardium but not in endocardium appears to contribute importantly to these differences. The the two tissue types. The presence of a spike and dome evidence in support of the hypothesis that these differences between epicardium and endocardium are due to the presence of an It, more prominent in epicardium than in endocardium.7-9 Recent work10-'4 also indicates that the prominent presence of 'to in epicardium but not in endocardium contributes to differences in the time and rate dependence of action potential duration (APD) and refractoriness in the two tissue types as well as to the rate-dependent changes in the T wave and J (Osborn) wave in the electrocardiogram; the presence of 1,0 also contributes to the greater sensitivity of epicardium to ischemia and to the differential effects of various pharmacological agents on epicardium and endocardium.
Although the electrophysiological actions of sodium channel block have been well characterized in Purkinje and endocardial preparations,15-20 in vitro investigations of the actions of sodium blockers in epicardium are limited.12 The present study was designed to contrast the electrophysiological actions of sodium channel blockade in canine ventricular epicardium and endocardium and to test the hypothesis that the marked differences in the response of the two tissues to sodium channel block is, in part, due to the presence of an I, more prominent in epicardium than in endocardium.
Materials and Methods
Papillary muscles, right ventricular trabeculae, and right ventricular epicardial strips (-2.0x 1.5 x0.2 cm) were isolated from hearts removed from anesthetized (30 mg/kg body wt sodium pentobarbital) mongrel dogs of either sex (18-26 kg) . The epicardial preparations were obtained by razor blade shavings (Dermatome power handle 3293 with cutting head 3295, Davol Simon, Cranston, R.I.) made parallel to the fiber orientation in the right ventricular free wall. Because we found no major differences between the characteristics of papillary muscles and trabeculae, we grouped these together in the presentation of results. No significant differences could be discerned between the activity of intact papillary muscles and that of strips shaved from the surface of these muscles. The terms endocardial and epicardial in this report refer to the muscle cells on the respective surfaces of the ventricular wall representing the outermost subendocardial and subepicardial layers.
Epicardial and endocardial preparations from the same heart were placed in a tissue bath and allowed to equilibrate while superfused with an oxygenated (95% 02-5% C02) Tyrode's solution (37+0.50C, pH 7.35). Unless otherwise indicated, the composition of Tyrode's solution was (mM) NaCl 129, KCl 4, NaH2PO4 0.9, NaHCO3 20, CaCl2 1.8, MgSO4 0.5, and D-glucose 5.5.
The tissues were stimulated at basic cycle lengths ranging from 200 to 2,000 msec using rectangular stimuli (1-3 msec, 2.5 times diastolic threshold intensity) delivered Experiments were not started until the preparations were fully recovered and displaying stable electrophysiological characteristics. In the case of the epicardial sheets, this sometimes took .3 hours; the spike and dome morphology of the epicardial action potential was usually much attenuated when the tissue was first introduced into the bath and recovered slowly as the tissue hyperpolarized (washout of residual catecholamines leaking out of sympathetic nerve endings may have contributed to this).
Restitution of action potential variables (i.e., progressive changes in the action potential characteristics of premature beats as they are introduced progressively later in diastole) was determined with the use of a single test pulse (S2) delivered after every fifteenth basic beat (S,). The S1-S2 coupling interval was increased progressively from the end of the refractory period until the next basic beat. The effective refractory period (ERP) was defined as the longest S1-S2 interval at which S2 failed to elicit a propagated response.
Drugs
4-Aminopyridine (Sigma Chemical Co., St. Louis) was dissolved in distilled water and made soluble by warming to yield a stock solution of 0.5 M. The pH of the stock was adjusted to 7.4 with HCl. Because 4-aminopyridine has been reported to cause release of neurotransmitters from adrenergic and cholinergic nerve endings,21 the combination of propranolol (0.3 ,ug/ml), phentolamine (1.0 ,g/ml), and atropine (1.0 ,ug/ml) was assessed in the initial experiments. Use of these agents was discontinued when it was determined that they did not alter the actions of 4-aminopyridine. Ryanodine Figure 1 , Panel A shows a progressive decrease in Vm., amplitude, and duration of action potentials recorded from a papillary muscle preparation during a 4-hour period of exposure to DLpropranolol (1 ,ug/ml). In contrast to the abbreviation of APD in endocardium, propranolol produced a marked prolongation of APD in epicardium during the first 3 hours of exposure to the drug ( Figure 1B In both epicardium and endocardium, the propranolol-induced electrophysiological changes developed gradually over a period of several hours. The time course for development of the propranolol-induced changes in phase 0 amplitude and APD for the preparations pictured in Figure 1 are graphically illustrated in Figure 2 . In endocardium, APD changes paralleled those of phase 0 amplitude (Figure 2A) . In epicardium, however, the progressive decrease of phase 0 amplitude was accompanied by a progressive increase of APD, until a further sharp decline in phase 0 amplitude during the fourth hour of exposure to the drug caused an abrupt abbreviation of APD ( Figure 2B ). With As an initial test of this hypothesis, we examined the effects of TTX (2-3 ,uM), a selective blocker of the sodium channels. The effects of TTX to diminish Vm,,,, phase 0 amplitude, and APD in Purkinje fibers and muscle preparations is well known.15161820,23 These actions of TTX are illustrated in Figure 3 .
ITX (3 ,uM) diminished Vm., and phase 0 amplitude in both epicardium and endocardium. These changes were accompanied by an abbreviation of APD in endocardium but a prolongation of APD in epicardium. With longer exposure of epicardium to TTX, the dome was abolished, resulting in a marked abbreviation of APD. In five experiments, APD of epicardium was prolonged an average of 11.1+6.3 msec (p<0.05), whereas the APD of endocardium was abbreviated by 10.8± 12.9 msec (p<0.05) after 15 minutes of exposure to 2 ,M TTX (BCL=1,000 msec).
The effects of TTX and their similarity to those of propranolol (compare Figures 1 and 3 ) provide support for the hypothesis that a paradoxical prolongation of APD in epicardium can result as a consequence of a decrease of phase 0 brought about by inhibition of INa As a further test of the hypothesis, we examined the correlation between concurrent changes in different phases of the epicardial action potential during the progressive development of APD prolongation by exposure to propranolol. To explain the differential effects of sodium channel block on epicardium and endocardium, we considered the hypothesis that differences in the responsiveness of the two tissues to the drug were, in large part, due to the presence of an 10-mediated spike and dome (notch) in epicardium but not in endocardium.
As an initial test of this hypothesis, we examined the rate dependence of action potentials in epicardium and endocardium in the presence of propranolol or TTX (Figures 6-8) . Figure 6 illustrates the effects of an abrupt acceleration (panel A) and deceleration (panel B) on transmembrane activity in epicardium and endocardium after 20 minutes of exposure to DL-propranolol (3 ,ug/ml). In endocardium, deceleration resulted in an increase in the amplitude and duration of the action potential, and acceleration produced the opposite effects. Under the same con- ditions, the changes in epicardium were considerably more remarkable. At a BCL of 2,000 msec, the epicardium response was devoid of a plateau. Acceleration to a BCL of 500 msec promptly restored the plateau, thus dramatically prolonging the action potential. These changes were attended by an increase in the amplitude of phase 1 but a decrease in the amplitude of phase 0. The restoration of the plateau and the accompanying increases in the amplitude of phase 1 are effects that are consistent and expected, based on the fact that Ito is known to be relatively slow to reactivate.1 Acceleration, therefore, leads to a decrease in the availability of 'to, which, in turn, gives rise to the paradoxical effects seen in epicardium. The decrease of phase 0 amplitude is also expected, based on the fact that propranolol's block of the sodium channels is use dependent. Deceleration from a BCL of 300 to 2,000 msec results in abolition of the dome, abbreviation of APD, and a marked accentuation of phase 1 ( Figure 6B ). Figure 7 illustrates another variation on this theme. In endocardium, acceleration of BCL from 500 to 300 msec results in the expected abbreviation of APD and decrease in amplitude. In epicardium, the dome is abolished at a BCL of 500 msec, and acceleration results in a transient appearance of the plateau. The gradual development of sodium channel block (use dependent) at the shorter BCL is likely responsible for the subsequent abolition of the dome.
When drug-induced block of the sodium channel was less intense, the dome of the action potential was not lost at physiological rates of stimulation. Under these conditions, acceleration of basic drive resulted in a progressively larger drug-induced prolongation of the APD at progressively shorter BCLs, as illustrated for propranolol in Figure 8 . In this example, exposure of the epicardial preparation to a P-adrenergic blocking concentration of DL-propranolol (0.2 ,ug/ml) produced a slight upward shift of the APDrate relation. Increasing the concentration to 3 ,ug/ml resulted in a larger upward shift and a flattening of the relation. The prolongation of APD after 3 ,ug/ml DL-propranolol was more pronounced at the faster frequencies (possibly because of the use dependence of propranolol's local anesthetic effects). The composite results of eight similar experiments are presented in Figure 8B : propranolol (3 ,ug/ml) prolonged APD by 14.7% at a BCL of 2,000 msec and by 23.3% at a BCL of 300 msec. Figure 9 illustrates restitution characteristics of transmembrane responses recorded from endocardium and epicardium after 270 minutes of exposure to propranolol (1 ,g/ml, BCL=2,000 msec). The first beat in each panel is the last of a train of 15 basic beats. Subsequent beats represent premature responses introduced progressively later in diastole, once after every fifteenth basic beat. The restitution characteristics in endocardium are unremarkable. In epicardium, early premature beats show a restoration of the action potential dome, which is lacking in the basic beats and in responses elicited later in diastole. Once again, the restoration of the dome is attended by an increase in the amplitude of phase 1 that is consistent with a decreased contribution of In,. As Ito reactivates, phase 1 becomes progressively more prominent until it brings the membrane potential to a voltage at which the dome fails to appear. Figure 10 shows similar restitution characteristics recorded from epicardium after exposure to TTX (2 ,uM). Figure 10B illustrates the recovery of Vm.. Restoration of the action potential dome occurs at a time when Vmax is at its lowest level and is once more abolished when Vm,t, is largely recovered. Also noteworthy is the progressive decline in the phase 0 amplitude during the first three premature beats at a time when Vmax is increasing. These data suggest that restitution of action potential characteristics in epicardium is importantly influenced by the recovery of Ito and provide further support for the hypothesis that the differences in the responsiveness of the two tissues to sodium channel block are due, in large part, to the presence of a prominent Ito in epicardium but not in endocardium.
As a further test of this hypothesis, we examined the effects of propranolol and TTX in preparations pretreated with 4-aminopyridine, anInT blocking agent. In the absence of 4-aminopyridine, YTX abbreviated APD in endocardium but prolonged it in epicardium ( Figures 11A and llB) Figure 12 . Panels A and B show the effects of propranolol (3 ,ug/ml, 40 minutes) on the rate dependence of APD and ERP in epicardium and endocardium. ERP in this experiment was determined using S2 pulses with an intensity two and a half times diastolic threshold. In endocardium ( Figure  12A ), the propranolol-induced changes were unremarkable and consisted of a decrease in APD and ERP at all frequencies, producing a downward shift of the curves. In epicardium, however, propranolol produced an upward shift and a flattening of the APD-rate relation and a reversal of the ERP-rate relation characterized by a marked increase in ERP at the faster rates of stimulation. At a BCL of 500, APD increased by about 15 msec, whereas ERP increased from 166 to 378 msec. ERP and APD could not be determined at BCLs shorter than 500 msec because of the loss of 1:1 activation at these rates. Figure 12C shows results obtained from another epicardial preparation before and after similar treat- ment (3 ,ug/ml propranolol, 45 minutes) but using test pulses of four times diastolic threshold intensity. Propranolol produced a flattening of both the APDand ERP-rate relations.
The effects described above likely contribute importantly to the antiarrhythmic actions of sodium blockers but may also be responsible for some of the arrhythmogenic or proarrhythmic actions of these agents. An example of arrhythmogenic activity precipitated by a heterogeneous response to sodium blockade is illustrated in Figure 13 . Figure 13 shows transmembrane recordings from two sites in an epicardial sheet obtained after 40 minutes of exposure to flecainide (15 MM). At a BCL of 1,000 msec, the action potential dome was lost at both sites. A premature stimulus introduced at an S1-S2 interval of 145 msec elicited a response devoid of a dome at the proximal site but a response in which the dome was fully restored at the distal site. As a consequence of the large difference in repolarization times at the two sites, and perhaps other factors, a reentrant beat appeared at the proximal site (third beat in bottom tracing). In other experiments, induction of epicardial reentry after exposure to flecainide could be readily achieved after either premature stimulation or after acceleration of the stimulation rate. Although the precise mechanism for the reentrant activity cannot be discerned from the available data, the results suggest that heterogeneity in the response of "normal" epicardium to sodium block can readily set the stage for reentry and other arrhythmias.
Discussion
Class I antiarrhythmic agents are among the most widely used of antiarrhythmic drugs. Although grouped into three subclasses, all possess the ability to block the sodium channels in cardiac tissues. Sodium channel block is a feature common to many other antiarrhythmics as well. The electrophysiological effects of sodium channel block have generally been thought to be quite uniform, straightforward, and, therefore, well understood. They generally consist of 1) suppression of the rate of rise (Vma) and the amplitude of phase 0 of the action potential via inhibition of the fast INa and 2) abbreviation of APD secondary to block of the sodium "window currents" or slowly inactivating TTX-sensitive sodium current. 15, 20, 23 Our data demonstrate for the first time an effect of sodium channel block to prolong APD in ventricular myocardium in vitro. The results point to a heterogeneous and, in some cases, opposite response of epicardial and endocardial ventricular tissues to sodium channel block and delineate a novel mechanism by which flecainide and other sodium channel blockers may produce proarrhythmic effects. Notably, none of the three agents significantly affected Ito. spect to our understanding of cardiac electrophysiology, electrocardiography, pathophysiology, and pharmacology. The presence of a prominent 10-mediated spike and dome in action potentials recorded from epicardium but not from endocardium is thought to contribute to the selective depression of epicardium during ischemia,10'26 the manifestation of an Osborn or J wave in the electrocardiogram,3 differences in the rate dependence of APD and refractoriness in the two tissue types, and differences in the sensitivity of these two tissues to K', Ca2+, and a variety of pharmacological agents including quinidine, 4-aminopyridine, ryanodine, calcium blockers, amiloride, acetylcholine, and isoproterenol.1011"13'27 The present study demonstrates similar differences in the responsiveness of epicardium and endocardium to sodium channel block.
Sodium channel block was achieved in this study with either TTX, DL-propranolol, or flecainide. TTX is a highly specific blocker of the sodium channel and is known to block the cardiac sodium channel in a use-dependent manner.28,29 After TTX exposure, the amplitude and Vm., of phase 0 reach a steady state fairly quickly; this occurrence depends principally on equilibration of 'ITX with the extracellular space (time constant of -10 minutes in canine epicardium30). Propranolol is a f8-adrenergic blocker with reasonably specific actions: cardiac sodium channels are blocked at concentrations of 0.2-3 ug/ml. Blocking of the sodium channel by propranolol is known to develop very slowly over a period of hours and to be linked to the slow tissue uptake (intracellular accumulation) of the drug. 22 Our results show a slow onset of propranolol's electrophysiological actions in canine ventricular epicardium and endocardium as well as a slow washout of these effects, consistent with these earlier studies. With concentrations of the drug producing nearly comparable decreases in Vm., propranolol produced an abbreviation of APD in endocardium that was approximately twice that produced by TTX (23.8 +5.6 versus 10.8+12.9 msec) and a prolongation of APD in epicardium that was greater than threefold that produced by TTX (34.4± 11.3 versus 11.1+6.3 msec) at a BCL of 1,000 msec. These differences may be due to a number of factors. Chief among these is the lack of specificity of propranolol as a sodium channel blocker; because it antagonizes any residual adrenergic tone (through spontaneous release of catecholamines from the adrenergic nerve endings), propranolol would be expected to exert a prolonging effect on APD and thus could accentuate the effects of sodium blockade in epicardium but antagonize them in endocardium (see Figure 8) . The extent to which these factors influence our results awaits more detailed study. It is noteworthy that in a corollary study'3 we have recently found that isoproterenol abbreviates APD to a greater extent in epicardium than in endocardium. Comparison of the effects of propranolol and flecainide under similar conditions shows that the two produce a more comparable prolongation of APD in epicardium (Tables  1 and 2 ), although the effect of propranolol was consistently greater than that of flecainide.
Our results appear to be at odds with those of Gilmour and Zipes,12 who showed that TTX abbreviates action potentials recorded from isolated canine endocardial as well as epicardial tissues. The reason for the discrepancy is not clear but may be due to several factors. Chief among these is the virtual absence of a spike and dome morphology in action potentials recorded from their epicardial preparations and the higher concentration of TTX (5 ,uM) used. The small notch may be related to their use of younger animals, since the spike and dome morphology is known to be absent in the neonate and to become progressively more prominent with age,31'32 or it may be related to a briefer equilibration of the tissues after isolation.
The prolongation of ventricular refractoriness (epicardial) by 1TX and propranolol has previously The data presented in our study support the hypothesis that the paradoxical prolongation of APD in epicardium is due, in large part, to a decrease in the amplitude of phases 0 and 1 (secondary to sodium channel block), which, in turn, alters the intensity and kinetics of several ionic currents, causing subsequent phases of the epicardial action potential to be shifted with respect to time and voltage ( Figures  1-4) . In this schema, a decrease of inward current in the early phases of the action potential contributes to a diminution of phase 0 amplitude and termination of phase 1 at more negative potentials. The availability of 1Ca at these more negative potentials is diminished, thus causing a slowing or delay in the emergence of the second upstroke. The net inward current at the end of phase 1 may also be diminished because the sodium blockers inhibit the slowly inactivating and window sodium currents.15, '6,23 The delay in the development of the second upstroke is usually attended by an increase in the voltage of the plateau phase. A correlation between phase 1 amplitude and plateau height is also observed in epicardium after changes in the rate or prematurity of stimulation.14 The reason for the increase in the height of the Flecainide differs from TTX and propranolol in that accentuation of the spike and dome is not accompanied by an increase in the voltage of the peak plateau (possibly because of an effect of the drug on calcium currents at concentrations > 10 gM36).
Another major difference in the responsiveness of epicardium and endocardium to sodium channel block is the marked abbreviation observed in epicardium after abolition of the dome. The same basic mechanism outlined above may explain these actions of sodium blockers. When the termination of phase 1 shifts to potentials negative to the threshold voltage for activation of 'Ca, the outward currents would be expected to overwhelm any activated inward currents, resulting in an all-or-none repolarization and marked abbreviation of APD.
To explain the differential effects of sodium blockade on epicardium and endocardium, we considered the hypothesis that differences in the responsiveness of the two tissues to the drugs were, in large part, due to the presence of an It.-mediated spike and dome (notch) in epicardium but not in endocardium. The rate and time dependence of these effects of sodium channel block in epicardium and endocardium (Figures 6-10) as well as the elimination of the differences in the responsiveness of the two tissues when pretreated with the 'to blocker 4-aminopyridine (Figure 11 ) provide strong evidence in support of the hypothesis.
The differential effects of sodium blockade on the excitability or responsiveness of the two tissue types, although somewhat tangential to the scope of the present study, are included for completeness. The development of postrepolarization refractoriness in epicardium but not in endocardium was a consistent finding ( Figure 12 ). This effect of sodium blockade may help explain recent reports of a differential effect of chronic amiodarone treatment on epicardial and endocardial tissues.37,38 Full characterization of these differences and elucidation of the underlying mechanism await further study. The dramatic increase in refractoriness with acceleration of the stimulation rate is seen when the intensity of the stimulus is relatively weak (2.5 times diastolic threshold, Figure 12 ). This type of behavior might be representative of the behavior expected when the intensity of the activating wave front is diminished because of underlying disease (e.g., complex anisotropy due to fibrosis or surviving islands of activity after infarction) or the behavior resulting from the fractionation of wave fronts like that occurring during ventricular fibrillation. When the intensity of the test stimulus is increased, the changes in ERP of epicardium parallel those of APD, resulting in a flattening of the ERP-rate relation ( Figure 12C ). This behavior may be more representative of the behavior expected in tissue activated by a normal wave front.
By the same token, sodium channel block in epicardium, when sufficiently great to cause loss of the action potential dome and marked abbreviation of APD, can dramatically increase the degree of dispersion of refractoriness and thus exert an arrhythmogenic or proarrhythmic effect ( Figure 13 ). This type of dispersion has been demonstrated after simulated ischemia in canine ventricular epicardial and endocardial tissues26 and in response to acetylcholine13 and hypothermia.10 The resulting heterogeneity provides an ideal substrate for the development of reentry. Our data suggest that a nonuniform response to sodium channel blockade can contribute to the development of a large dispersion of refractoriness in normal ventricular tissues and that this effect may be intensified under conditions of ischemia.
The presence of a prominent spike and dome morphology in M cells in the deep subepicardial layers of the canine ventricle40 raises the possibility that similar effects of sodium block may occur in more than just the epicardial surface.
The dispersion of APD in response to sodium channel blockade may occur between epicardium and endocardium ( Figures 1, 3, 6 , and 7) as well as between neighboring epicardial sites ( Figure 13) . A greater dispersion between epicardium and endocardium may be expected with flecainide than with either ITX or propranolol, because loss of the dome in epicardium is accompanied by an abbreviation of APD in endocardium after exposure to TTX and propranolol, whereas a prolongation of APD in endocardium occurs after exposure to flecainide36 beand/or inducing postrepolarization refractoriness in cause of its inhibition of 1K.41
Acceleration-induced loss of the dome is observed more readily with flecainide than with TTX or propranolol, possibly because of its more accentuated use-dependent block of the sodium channels (acceleration decreases INa more than it reduces It0). A weak inhibition of 'Ca by flecainide may also contribute to this effect. The tachycardia dependence of this potentially arrhythmogenic effect of flecainide is consistent with clinical reports that indicate that the proarrhythmic effects of the drug are generally exercise-induced and are related to the drug-induced slowing of ventricular conduction, as evidenced by rate-dependent increases in QRS duration. [42] [43] [44] 
